Coronary heart disease risk prediction by general practitioners in Victoria

• 1 Department of Epidemiology and Preventive Medicine, Monash University, and Department of Public Health, Erasmus Medical Centre, PO Box 1738, Rotterdam, 3000DR, The Netherlands
• 2 Geelong Hospital, Geelong, VIC
• 4 Department of Epidemiology and Preventive Medicine, Monash University, Prahran, VIC.

---

• 1. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998; 19: 1434-1503.
• 2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
• 3. National Heart Foundation of Australia, The Cardiac Society of Australia and New Zealand. Lipid management guidelines — 2001. Med J Aust 2001; 175 (9 Suppl): S57-S85. Available at: www.heartfoundation.com.au/downloads/lipid_guide_2001.pdf (accessed Jan 2004).
• 4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
• 5. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998; 339: 1349-1357.
• 6. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279: 1615-1622.
• 7. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-1306.